Back

FABRY DISEASE OR SARCOMERIC HYPERTROPHIC CARDIOMYOPATHY?

29 May 2018 (10:17 - 10:21)
Organised by:
Congress Presentation Part of: Clinical Case Corner 6 - Such a big, big heart: cases of (pseudo)hypertrophy Diagnostic Methods HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Hedvig Takacs

University of Szeged, Szeged (Hungary)

10 More presentations in this session

Presentation thumbnail
Hypertrophic obstructive cardiomyopathy: a disguise for fabry disease?
Doctor S. Militaru (Craiova, RO)
Abstract
Presentation thumbnail
TTR familial amyloidosis - never forget phenocopies in hypertrophic cardiomyopathy
Mrs A. Mursa (Bucharest, RO)
Abstract
Presentation thumbnail
Double silent threat- case report of asymptomatic patient with cardiac transthyretin amyloidosis and multivessel coronary artery disease
Ms M. Gawor (Warsaw, PL)
Abstract
Presentation thumbnail
Surgical treatment of hypertrophic obstructive cardiomyopathy in a patient with prior alcohol septal ablation and artificial cardiac pacemaker
Miss P. Danchenko (Kiev, UA)
Abstract
Presentation thumbnail
Acute massive pulmonary edema and cardiogenic shock: an unusual presentation of hypertrophic obstructive cardiomyopathy
Doctor V. Thomachan (Al Ain, AE)

Access the full session

Session thumbnail
Clinical Case Corner 6 - Such a big, big heart: cases of (pseudo)hypertrophy

The Event

Event poster

Heart Failure 2018

29 May 2018 10:17 CET
You may be interested in
thumbnail
Congress Presentation
Fabry disease and hypertrophic cardiomyopathy: similar albeit different
26 August 2022
thumbnail
Congress Session
Clinical course of specific cardiomyopathies
18 May 2025
thumbnail
Congress Presentation
Myocardial determinants of Functional limitation in advanced Fabry cardiomyopathy
1 September 2024
thumbnail
Webinar
Elevating cardiac expertise: practical approach to left ventricular hypertrophy phenotypes assessment
19 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources